UVB-Induced Tumor Heterogeneity Diminishes Immune Response in MelanomaYochai Wolf, Yardena Samuels, Sophie Trabish et al.|Cell|2019Cited by 394
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanomaShelly Kalaora, Yardena Samuels, Joo Sang Lee et al.|Nature Communications|2020Cited by 156
Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in MelanomaShelly Kalaora, Yardena Samuels, Yochai Wolf et al.|Cancer Discovery|2018Cited by 100
CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanomaMichal Alon, Yardena Samuels|Oncotarget|2018Cited by 15